Comparing effect of perioperative intravenous dexamethasone in ACDF on post operative dysphagia : Randomized Controlled Trial

Status

Unknown

Phases

Phase 2

Study type

Interventional

Source

TCTR

Registry ID

TCTR20240920003

Enrollment

Registered

2024-09-20

Start date

2024-03-31

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patient undergo the operation Anterior Cervical Discectomy and Fusion Diskectomy Dexamethasone

Interventions

PRE-OPERATIVE: intravenous dexamethasone 0.3 mg/kg (maximum dose 20 mg) 30 minutes before surgery,PRE-OPERATIVE: intravenous dexamethasone 0.3 mg/kg (maximum dose 20 mg) 30 minutes before surgery P

Experimental Drug,Experimental Drug

pre operative intravenous dexamethasone,pre and pose operative intravenous

Eligibility

Sex/Gender

All

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: (1) Patients age over 18 year old undergo the operation Anterior Cervical Discectomy and Fusion at Lerdsin Hospital between March 2024 - June 2025 (2) Patients who understand Thai language

Exclusion criteria

Exclusion criteria: (1) Revision surgery (2) Combined approach between anterior and posterior approach (3) Regular use of steroid (4) Undergoing ACDF due to traumatic indication (5) Allergic to steroid (6) Pregnancy (7) Uncontrolled Diabetes Mellitus (8) Cognitive impairement

Design outcomes

Primary

Measure	Time frame
Dysphagia (By Bazaz score) 16 months Bazaz score	—

Secondary

Measure	Time frame
Dysphagia (by Dysphagia short questionnaire) 16 months Dysphagia short questionnaire	—

Countries

Thailand

Contacts

Public ContactTanaphat Suebsantiwongs

Lerdsin Hospital

ryan_pun@hotmail.com0818017354

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026